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Background: Neurocognitive dysfunction remains a limitation of cardiac surgery
with cardiopulmonary bypass. Intraoperative cerebral microembolization is believed
to be one of the most important etiologic factors. Using a new generation of
transcranial Doppler ultrasonography, we compared the number and nature of
intraoperative microemboli in patients undergoing on-pump and off-pump cardiac
surgery procedures.
Methods: Bilateral continuous transcranial Doppler monitoring of the middle cere-
bral arteries was performed in 45 patients (15 off-pump coronary artery bypass
grafting, 15 on-pump coronary artery bypass grafting, and 15 open cardiac proce-
dures). All recordings were performed using a multi-range, multifrequency system
to allow both measurement of the number and discrimination of the nature of
microemboli in the 3 different groups.
Results: The median number (interquartile range) of microemboli in the off-pump
coronary artery bypass grafting, on-pump coronary artery bypass grafting, and open
procedure groups were 40 (28-80), 275 (199-472), and 860 (393-1321), respectively
(P  .01). Twelve percent of microemboli in the off-pump coronary artery bypass
grafting group were solid compared with 28% and 22% in the on-pump coronary
artery bypass grafting and open procedure groups, respectively (P  .05). In the
on-pump groups, 24% of microemboli occurred during cardiopulmonary bypass,
and 56% occurred during aortic manipulation (cannulation, decannulation, applica-
tion, and removal of crossclamp or sideclamp).
Conclusions: Cerebral microembolization is significantly reduced with avoidance of
cardiopulmonary bypass. The majority of microemboli occurring during cardiac
surgery are gaseous, with a higher proportion of solid microemboli in the on-pump
group, and may have a different significance for cerebral injury than solid micro-
emboli. The ability to reliably discriminate gas and solid microemboli may have an
important role in the implementation of neuroprotective strategies.
Cerebral injury is a major cause of mortality and morbidity aftercardiac surgery and occurs in 2 distinct forms. Overt injury, usuallya stroke, occurs in 3% of patients undergoing coronary arterybypass grafting (CABG), whereas injury leading to cognitive im-pairment, only evident on detailed neuropsychologic testing,1-3occurs in up to 80% of all patients soon after surgery and persists
in one quarter of these at 6 months.4 Early postoperative cognitive impairment
correlates with later progression of cognitive decline and impaired quality of life.5,6
Cardiopulmonary bypass (CPB) can cause brain injury through several mecha-
nisms, but microembolization is believed to be the most important. Pugsley and
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colleagues7 demonstrated that postoperative neuropsycho-
logic deficits are related to the number of cerebral micro-
emboli after routine CPB.
High-intensity transient signals (HITS), detected using
transcranial Doppler (TCD) ultrasonography, result from an
increase in the ultrasound signal reflected from the micro-
emboli compared with the surrounding blood and can pro-
vide an index of microemboli entering the cerebral circula-
tion. However, an increase in the ultrasound signal can also
result from artifacts caused by movement. Until recently, it
was not possible to differentiate objectively between arti-
facts and emboli or to discriminate between solid and gas-
eous microemboli. With the availability of a multifrequency
TCD system (EmboDop; DWL Elektronische Systeme
GmbH, Singen, Germany), online artifact rejection and au-
tomatic discrimination between solid and gaseous microem-
boli are now achievable with high sensitivity and specific-
ity.8,9 This technique depends on insonating an embolus
using 2 different frequencies. A solid embolus would reflect
more ultrasound at the higher compared with the lower
frequency, whereas the opposite occurs with gaseous mi-
croemboli. This study quantified the number and nature of
intraoperative microemboli in patients undergoing various
cardiac surgery procedures.
Material and Methods
Patient Groups
A total of 45 patients undergoing first-time cardiac surgery were
prospectively recruited for the study. All patients gave informed
consent, and full ethical approval was obtained from the local
research ethics committee (Oxford Research Ethics Committee
number C01.258). The patients were divided into 3 groups. Fifteen
patients underwent off-pump CABG (OPCABG), 15 patients un-
derwent on-pump CABG (ONCABG), and the remaining 15 pa-
tients underwent valve replacement with or without CABG: aortic
valve replacement (12 patients), aortic valve replacement and
CABG (2 patients), and mitral valve replacement and CABG (1
patient). Patients with symptomatic carotid disease or atrial fibril-
lation were excluded.
CPB
After full anticoagulation with heparin given at a dose of 300
IU/kg to maintain an activated clotting time of 400 to 600 seconds,
CPB was instituted using ascending aortic cannulation and a
2-stage right atrial venous cannulation. A roller pump (Jostra HL
20, Hirrlingen, Germany) and hollow-fiber membrane oxygenator
(Affinity NT; Medtronic Inc, Minneapolis, Minn) were used. The
extracorporeal circuit was primed with 1000 mL of Hartmann’s
solution and 2500 IU of heparin. CPB was maintained with non-
pulsatile flow with a flow rate of 2.4 L/m2/min at normothermia
with the temperature allowed to drift to 34°C. Arterial line filtra-
TABLE 1. Perioperative characteristics
OPCABG
CPB
P valueONCABG Open procedure
Number 15 15 15 —
Age, y (mean  SD) 62 11 66 9 61 15 *.25
†.93
‡.3
Females (n) 1 0 2 *†‡.34
Parsonnet score (mean  SD) 4.9 4.9 8.8 5.2 11.6 7.3 *.06
†.008
‡.3
EuroSCORE (mean  SD) 2.3 1.6 4.3 4.4 3.0 2.6 *.12
†.39
‡.33
Number of grafts (mean  SD) 2.9 0.7 3.0 0.6 — *.62
Bypass time, min (mean  SD) — 57 26 65 22 ‡.51
Crossclamp time, min (mean  SD) — 40 9 52 17 ‡.06
CABG, Coronary artery bypass grafting; OPCABG, off-pump CABG; ONCABG, on-pump CABG; CPB, cardiopulmonary bypass.
*Comparison of OPCABG versus ONCABG.
†Comparison of OPCABG versus open procedure.
‡Comparison of ONCABG versus open procedure.
TABLE 2. Number and proportion of gaseous and solid
microemboli detected in three patient groups
Procedure
Microemboli
Total median
(IQR)
Gaseous
(%)
Solid
(%)
OPCABG 40 (28–80)* 88 12†
ONCABG 275 (199–472)* 72 28†
Open procedures 860 (393–1321)* 78 22†
IQR, Interquartile range.
*Comparison of the total number of microemboli between the 3 groups: P
 .01.
†Comparison of the proportion of gas and solid microemboli in the 3
groups: P  .05.
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tion was not used. Cardiotomy suction was used. Acid-base was
managed with alpha stat control. Myocardial protection was
achieved with intermittent antegrade cold crystalloid cardioplegia.
On completion of all distal anastomoses, the aortic crossclamp was
removed, and the proximal anastomosis was performed with par-
tial aortic clamping.
Off-Pump Technique
Complete anticoagulation with heparin was achieved as in the CPB
group. Regional myocardial immobilization was achieved with a
suction stabilizer (Octopus, Medtronic Inc or Guidant; Guidant
Corporation, Santa Clara, Calif). The target coronary vessels were
snared proximally with a silastic sling. An intracoronary shunt
(Guidant Axius) was used only when there was hemodynamic
compromise during construction of the anastomosis (usually the
distal right coronary artery). Visualization was enhanced by using
a surgical blower-mister device (Medtronic Clearview, Medtronic
Inc). All patients had composite arterial grafts with complete
avoidance of aortic manipulation.
TCD Monitoring
Continuous intraoperative monitoring was performed using a mul-
tifrequency Doppler system (Embodop, DWL). Dual frequency
probes (2.0 and 2.5 MHz) were used to simultaneously insonate
the middle cerebral arteries (MCAs) bilaterally. The probes were
fixed to the transtemporal windows above the right and left zygo-
matic arches using a specifically designed head brace. The MCA
insonation depth was set between 45 and 55 mm with a sample
volume of 13 mm. An additional 2.0 MHz insonation reference
gate was set 15 mm superficial to the MCA insonation gate. This
reference gate serves for the online rejection of artifacts because
the latter are identified when HITS are detected in both gates
(MCAs and reference gates) simultaneously or with a time delay of
less than 4 milliseconds.
Figure 1A. HITS seen after aortic crossclamp removal. The top and bottom traces represent the 2.0 and 2.5 MHz
middle cerebral artery gates, respectively. The middle trace represents the 2.0 MHz reference gate.
Figure 1B. Rejection of artifacts and differentiation into gaseous
and solid microemboli during off-line analysis.
Abu-Omar et al Cardiopulmonary Support and Physiology
The Journal of Thoracic and Cardiovascular Surgery ● Volume 127, Number 6 1761
CS
P
This multifrequency system (2.5 MHz and 2.0 MHz) also
differentiates between solid and gaseous microemboli. Solid mi-
croemboli reflect more ultrasound at higher than at lower frequen-
cies, contrary to what occurs in the case of gaseous microemboli.
The differentiation occurs online during monitoring, and the data
are recorded on a computer hard drive that also allows off-line
analysis to be performed.
Statistical Analysis
Patient characteristics are presented as mean  SD. Normally
distributed data were compared using the Student t test. Categoric
variables were compared using the 2 test. The number of HITS is
presented as median and interquartile ranges. Because the data are
not normally distributed, the nonparametric Kruskal-Wallis test
was used to compare the difference in microembolization among
the 3 groups.
Results
Patient characteristics are summarized in Table 1.
Only around 10% of all HITS were microemboli, with
the remaining 90% being rejected as artifacts. The median
(interquartile range) number of microemboli was 40 (28-80)
in the OPCABG group, 275 (199-472) in the ONCABG
group, and 860 (393-1321) in the open procedure group (P
 .01) (Table 2).
Solid microemboli accounted for 12% of all microemboli
in the OPCABG group compared with 28% and 22% in the
ONCABG and open procedure groups, respectively. The
proportion of particulate microemboli was significantly
higher in the on-pump groups compared with the OPCABG
group (P  .05) (Table 2).
In the on-pump group, the largest proportion of micro-
emboli occurred during aortic manipulation (cannulation,
decannulation, and application and removal of crossclamp
and sideclamp (Figure 1), accounting for 56% of the total,
whereas 24% occurred during CPB (Table 3). The extent of
gaseous and solid microembolization during the different
stages of OPCABG, ONCABG, and open procedures is
shown in Figures 2, 3, and 4.
Discussion
Our study adds to the understanding of the pathophysiology
of microemboli during cardiac surgery by using a new
generation of TCD that automatically rejects artifacts and
discriminates between gaseous and solid microemboli.
Comparison of cerebral microembolization in on-pump ver-
sus off-pump procedures has been reported.10 However, this
is the first report contrasting the nature of microemboli in
ONCABG, OPCABG, and open procedures. In comparison
with OPCABG, there is a 7-fold increase in microemboli in
ONCABG and a 22-fold increase in open procedures. Fur-
thermore, the proportion of solid microemboli was signifi-
cantly reduced in the off-pump group.
Cerebral microemboli have been implicated in the patho-
genesis of cognitive decline after CPB for more than a
decade.7,11,12 Various reports have demonstrated a positive
association between the number of intraoperative cerebral
microemboli detected by TCD and postoperative neuropsy-
chologic dysfunction. In addition, autopsy studies have re-
ported large numbers of lipid microemboli in the brains of
patients dying after cardiac surgery that correlated with the
duration of CPB.13
A recent report demonstrated a significant reduction in
the incidence of neuropsychologic impairment with avoid-
ance of CPB.14 Our study demonstrates the remarkable
reduction in the degree of microembolization, both gas and
solid, during OPCABG. This may account for the difference
in neuropsychologic impairment reported between patients
undergoing on-pump and off-pump procedures.10,14 The
clinical consequences, however, may be equally dependent
on the nature and number of microemboli identified using
TCD.
Particulate microemboli are generally assumed to be
potentially the most damaging. Until recently, it was not
possible to distinguish between gaseous and solid microem-
boli. We used a recently validated method9 to identify the
variation in the degree and nature of microembolism during
different cardiac surgery procedures. In addition, this tech-
nique allows automatic online rejection of artifacts, whereas
previously the human observer was regarded as the “gold
standard.” Gaseous microemboli as small as 3 m and solid
microemboli of 80 m in diameter can be reliably detected.9
The demonstration of the increase in particulate embolic
load to the brain of patients undergoing CPB highlights the
potential of the latter for causing cerebral injury, which is
most likely to be evident in higher risk patients. The avoid-
ance of CPB and aortic manipulation in the latter group has
been shown to significantly reduce postoperative neurologic
complications.15,16
What is the source of microemboli during OPCABG?
Although microemboli can be detected in the cerebral cir-
culation using TCD, the origin of these microemboli re-
mains speculative. In the case of total arterial revascular-
ization using composite arterial grafts (a “no-touch” aortic
technique), a likely source of gaseous microemboli is air
entering the coronary artery during arteriotomy and being
returned to the left ventricle through the Thebesian veins.
Another potential source of gas microemboli is through
injections into central venous lines. Microemboli in the
right side of the heart may then enter the systemic circula-
tion by paradoxic embolism through a patent foramen ovale
(present in up to 35% of the healthy population17) or after
transpulmonary passage. These mechanisms may also ex-
plain why cerebral microembolization occurs during major
non–cardiac surgery procedures, particularly during major
orthopedic operations.18,19
Particulate microemboli may form within the heart,
particularly the left atrial appendage and left ventricle. In
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on-pump cases, they can form within the bypass circuit if
anticoagulation is inadequate. Cholesterol microemboli
probably arise from the atherosclerotic aorta during ma-
nipulation,20 whereas use of the cardiotomy suction and
denaturation of proteins may result in lipid microembo-
lization during CPB.21 Furthermore, platelet and blood
cell aggregation occurring during CPB may add to this
microembolic load. Gaseous microemboli may enter the
circulation during flushing and filling of coronary con-
duits, at initiation of CPB, through the bypass circuit
after blood sampling and injection of drugs, and during
cardiac ejection after open procedures.22 The increase in
absolute numbers of gaseous microemboli during open
procedures is consistent with transesophageal echocar-
diographic findings even after vigorous de-airing proce-
dures.23 It must be noted, however, that differentiation
and quantitation of HITS is difficult when a large number
of microemboli pass through the sample volume simul-
taneously such as after removal of the aortic crossclamp
or sideclamp.8 This, however, serves to underestimate the
benefits of OPCABG in which there is a lack of such
embolic showers entering the sample volume simulta-
neously.
Cerebral injury remains one of the most important causes
of adverse outcomes after cardiac surgery. It particularly
affects elderly patients and those with other comorbidities
and is more common and severe after cardiac operations
performed using CPB.14 As a progressively older and sicker
population undergoes both cardiac and noncardiac surgery
procedures, the scale of the problem is likely to increase.
TABLE 3. Number and proportion of microemboli during different operative events in patients undergoing on-pump surgery
Operative event
Total gas and solid Gaseous Solid
Median (IQR)
Percentage of
total Median (IQR)
Percentage of
total gas
Median
(IQR)
Percentage of
total solids
Aortic cannulation and crossclamping 26 (8–67) 13% 41 (20–100) 13% 8 (3–30) 12%
During CPB 145 (60–265) 24% 108 (43–199) 24% 24 (9–76) 26%
Removal of aortic crossclamp,
sideclamping, decannulation
148 (56–504) 43% 123 (43–381) 42% 31 (6–135) 46%
Other (chest opening and closure,
harvesting of conduits)
11 (2–68) 20% 6 (1–59) 21% 2 (0–8) 16%
Figure 2. Gaseous and solid microembolization during the course of OPCABG. LAD, Left anterior descending; OM,
obtuse marginal; PDA, posterior descending artery.
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Indeed, we and others have documented that advanced age
is the strongest predictor of postoperative neurocognitive
impairment.3
Conclusion
Cerebral embolization remains a problem during CPB. This
can be minimized by performing off-pump surgery with
Figure 3. Gaseous and solid microembolization during the course of ONCABG. CPB, Cardiopulmonary bypass.
Figure 4. Gaseous and solid microembolization during the course of an open procedure. CPB, Cardiopulmonary
bypass.
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avoidance of aortic manipulation. The ability to reliably
discriminate the nature of cerebral microemboli has an
important potential role in targeting various prevention
strategies to improve neurologic outcome after cardiac op-
erations, particularly de-airing after open procedures.
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